ConductScience.org, home

Paper28838947

Key signaling pathways in thyroid cancer.

Zaballos MA and 1 other. J Endocrinol, 2017. Cited by 122 papers, by iCite.

Cite this record

ConductScience Library. Key signaling pathways in thyroid cancer. Papers, record 28838947. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28838947

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Key signaling pathways in thyroid cancer.
PubMed
Journal
J Endocrinol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
122
iCite
Relative citation ratio, by iCite
4.61
iCite
Revised in PubMed
2017-09-25
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zaballos MAMiguel A
2Santisteban PPilar

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, EnzymologicMajor topic
Gene Expression Regulation, NeoplasticMajor topic
MAP Kinase Signaling SystemMajor topic
Phosphatidylinositol 3-KinasesMajor topic
Thyroid NeoplasmsMajor topic
Humans

Cited by96

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.

PMIDTitleJournalYearIn PapersSource
42806342Synergistic role of molecular imaging and genomics in thyroid cancer management: from diagnosis to personalized treatment.J Transl Med2026https://conductscience.org/library/papers/42806342PubMed
42724449CircFN1 promotes invasion of papillary thyroid carcinoma cells by activating the PI3K/AKT pathway via the miR-29a/TRIB2 axis.Transl Cancer Res2026https://conductscience.org/library/papers/42724449PubMed
42719379Thyroid Cancer in the Modern Era: From Molecular Landscape and Multimodal Diagnostics to Integrative Traditional Chinese Medicine-A Comprehensive Review.Cancer Manag Res2026https://conductscience.org/library/papers/42719379PubMed
42559170Correction: Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42559170PubMed
42483678TSH suppression therapy from an individualized perspective: from mechanism to clinical decision-making.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42483678PubMed
42207379Development of metformin-encapsulated poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles.Mol Biol Rep2026https://conductscience.org/library/papers/42207379PubMed
42126497Glucose Metabolic Reprogramming in Thyroid Cancer: Underlying Molecular Mechanisms and Links to Progression and Treatment.Curr Med Sci2026https://conductscience.org/library/papers/42126497PubMed
42039113Multifocal papillary thyroid carcinoma with RET p.V804M, EML4-ALK fusion, and BRAF V600E positivity.JCEM Case Rep2026https://conductscience.org/library/papers/42039113PubMed
41851690Identification and validation of hub genes involved in papillary thyroid carcinoma progression.BMC Cancer2026https://conductscience.org/library/papers/41851690PubMed
41800331LncRNA VCAN-AS1 Sponges miR-374c-3p to Promote Proliferation, Invasion, Migration, and EMT in Thyroid Cancer.Int J Endocrinol2026https://conductscience.org/library/papers/41800331PubMed
41767494Advances in immunotherapy for thyroid malignancies: from molecular targets to clinical outcomes.Front Med (Lausanne)2026https://conductscience.org/library/papers/41767494PubMed
41675640Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41675640PubMed
41642503Therapeutic Potential of Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer.Curr Oncol Rep2026https://conductscience.org/library/papers/41642503PubMed
41271882A Comprehensive multi-network analysis of ceRNAs and transcription factors for papillary thyroid carcinoma diagnosis and prognosis.Sci Rep2025https://conductscience.org/library/papers/41271882PubMed
41196390The role of the primary cilium in thyroid function and dysfunction with implications for thyroid disease.Histochem Cell Biol2025https://conductscience.org/library/papers/41196390PubMed
41154428The Interplay Between lncRNAs-microRNAs Network Dysregulation and Cellular Hallmarks of Thyroid Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41154428PubMed
41021127Multidimensional transcriptomic and immune profiling of papillary thyroid cancer: bridging molecular networks, disease stage, survival outcomes, and drug discovery.Discov Oncol2025https://conductscience.org/library/papers/41021127PubMed
40880035Systemic Therapy for Advanced Thyroid Cancer-New Personalized Options.Drugs2025https://conductscience.org/library/papers/40880035PubMed
40819127Epigenetic control in thyroid cancer: mechanisms and clinical perspective.Cell Death Discov2025https://conductscience.org/library/papers/40819127PubMed
40806788Loss of SPRED3 Causes Primary Hypothyroidism and Alters Thyroidal Expression of Autophagy Regulators LC3, p62, and ATG5 in Mice.Int J Mol Sci2025https://conductscience.org/library/papers/40806788PubMed

See all 96 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28838947

GET https://conductscience.org/api/papers/v1/28838947/cited_by?page=2